Preferred Label : fostemsavir;

MeSH note : prodrug of BMS-626529, an HIV-1 attachment inhibitor; structure in first source;

CISMeF synonym : BMS-663068;

MeSH synonym : (3-((4-Benzoyl-1-piperazinyl)(oxo)acetyl)-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo(2,3-c)pyridin-1-yl)methyl dihydrogen phosphate;

Is substance : O;

UNII : 97IQ273H4L;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.ema.europa.eu/en/medicines/human/EPAR/rukobia
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Fostemsavir Tromethamine
Fostemsavir Tromethamine
fostemsavir
organophosphates
organophosphates
piperazines
piperazines
anti-hiv agents
anti-hiv agents
hiv infections
hiv fusion inhibitors
hiv fusion inhibitors
HIV-1
adult
acquired immunodeficiency syndrome
drug therapy, combination
drug resistance, multiple, viral
administration, oral
Delayed-Action preparations
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
prodrugs
Temsavir
drug evaluation, preclinical
fostemsavir
fostemsavir
multiresistant HIV-1 infection

---
https://www.has-sante.fr/jcms/p_3271861/fr/rukobia-fostemsavir
2021
false
false
false
France
administration, oral
Delayed-Action preparations
treatment outcome
insurance, health, reimbursement
fostemsavir
fostemsavir
adult
HIV-1
hiv infections
hiv fusion inhibitors
anti-hiv agents
drug resistance, multiple, viral
multiresistant HIV-1 infection
evaluation of the transparency committee
organophosphates
piperazines

---
https://ansm.sante.fr/tableau-atu-rtu/fostemsavir-600-mg-comprime-a-liberation-prolongee
2021
false
false
false
France
French
package leaflet
summary of product characteristics
guidelines for drug use
Fostemsavir
Fostemsavir
administration, oral
drug resistance, multiple, viral
hiv infections
HIV-1
drug therapy, combination
adult
anti-hiv agents
anti-hiv agents
fostemsavir
hiv fusion inhibitors
hiv fusion inhibitors
organophosphates
organophosphates
piperazines
piperazines
fostemsavir

---
Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.